556 results on '"Markert, James M."'
Search Results
2. High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictors
3. Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma
4. Immunovirotherapy for the Treatment of Glioblastoma and Other Malignant Gliomas
5. Transition From Manual to Automated Planning and Delivery of Volumetric Modulated Arc Therapy Stereotactic Radiosurgery: Clinical, Dosimetric, and Quality Assurance Results
6. Independent Validation of the Colloid Cyst Risk Score to Predict Symptoms and Hydrocephalus in Patients with Colloid Cysts of the Third Ventricle
7. A combined treatment regimen of MGMT-modified γδ T cells and temozolomide chemotherapy is effective against primary high grade gliomas
8. Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model
9. Author Correction: Positron emission tomography imaging with 89Zr-labeled anti-CD8 cys-diabody reveals CD8+ cell infiltration during oncolytic virus therapy in a glioma murine model
10. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models
11. Safety and efficacy of oncolytic HSV-1 G207 inoculated into the cerebellum of mice
12. Evaluating the Quality of Reporting and Transparency in the Neurosurgical Literature: How Well Are We Doing?
13. [89Zr]-CD8 ImmunoPET imaging of glioblastoma multiforme response to combination oncolytic viral and checkpoint inhibitor immunotherapy reveals CD8 infiltration differential changes in preclinical models.
14. Oncolytic virotherapies for pediatric tumors
15. Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults
16. Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care Unit
17. Oncolytic herpes simplex virus immunotherapy for brain tumors: current pitfalls and emerging strategies to overcome therapeutic resistance
18. Characterization of iPSCs derived from low grade gliomas revealed early regional chromosomal amplifications during gliomagenesis
19. Racial and socioeconomic disparities in glioblastoma outcomes: A single‐center, retrospective cohort study
20. Reshaping the anti-tumor CD4 T-cell repertoire contributes to oncolytic virus therapeutic efficacy in malignant glioma
21. Abstract 3576: Molecular imaging of CD8 infiltration following combination immunotherapy in preclinical glioblastoma
22. Data from STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells
23. Supplemental Cloning Methods from STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells
24. Supplemental Tables and Figures from STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells
25. Figure S7 from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
26. Data from Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
27. Understanding the Effect of Prescription Isodose in Single-Fraction Stereotactic Radiosurgery on Plan Quality and Clinical Outcomes for Solid Brain Metastases.
28. Engineered Herpes Simplex Virus Expressing IL-12 in the Treatment of Experimental Murine Brain Tumors
29. Supplementary Figure from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
30. Supplementary Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
31. Supplementary Data 3 from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
32. Data from Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
33. Supplementary Data 2 from A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma
34. Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma
35. Clinical advances in oncolytic virotherapy for pediatric brain tumors
36. Oncolytic Herpes Simplex Virotherapy for Pediatric Neuroendocrine Cancer
37. Safety and Efficacy of Intraventricular Immunovirotherapy with Oncolytic HSV-1 for CNS Cancers
38. Assessing the Impact of Changes to USMLE Step 1 Grading on Evaluation of Neurosurgery Residency Applicants in the United States: A Program Director Survey
39. Oncolytic Virotherapy for the Treatment of Malignant Glioma
40. Neurologic Physiology: The Brain and Its Response to Injury
41. Primary CNS Nonamyloidogenic Light Chain Deposition Disease: Case Report and Brief Review
42. Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression
43. Abstract CT541A: Oncolytic viral reshaping of the tumor microenvironment to promote CAR T cell therapy for glioblastoma
44. Oncolytic Viral Therapy Mediates its Effectiveness by Inducing and Enhancing CD4 cytotoxic T-cells
45. Viral therapy of glioblastoma multiforme
46. Plan quality and treatment planning technique for single isocenter cranial radiosurgery with volumetric modulated arc therapy
47. Prolonged treatment with bevacizumab is associated with brain atrophy: a pilot study in patients with high-grade gliomas
48. Immune Activity and Response Differences of Oncolytic Viral Therapy in Recurrent Glioblastoma: Gene Expression Analyses of a Phase IB Study
49. Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
50. High-dose Methotrexate and Rituximab Induction Regimen In Immunocompetent Patients With Primary CNS Lymphoma: A Retrospective Single-Center Study of Survival Predictors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.